Baron Health Care Fund Retail Shares (BHCFX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
19.37
+0.12 (0.62%)
May 1, 2024, 4:00 PM EDT
8.09% (1Y)
| Fund Assets | 230.84M |
| Expense Ratio | 1.10% |
| Min. Investment | $2,000 |
| Turnover | 51.83% |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | n/a |
| Previous Close | 19.25 |
| YTD Return | 0.53% |
| 1-Year Return | 3.91% |
| 5-Year Return | n/a |
| 52-Week Low | 16.68 |
| 52-Week High | 20.49 |
| Beta (5Y) | 0.80 |
| Holdings | 43 |
| Inception Date | Apr 30, 2018 |
About BHCFX
Under normal circumstances, the fund invests at least 80% of its net assets in equity securities in the form of common stock of companies engaged in the research, development, production, sale, delivery or distribution of products and services related to the health care industry. The Adviser uses various criteria to determine whether an issuer is engaged in activities related to the health care industry. It is non-diversified.
Fund Family Baron Capital Group, Inc.
Category Health
Performance Rating Above Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol BHCFX
Index Russell 3000 Healthcare TR
Performance
BHCFX had a total return of 3.91% in the past year. Since the fund's inception, the average annual return has been 11.88%, including dividends.
Other Share Classes
These are alternative share classes of the same fund, from the same provider.
| Symbol | Share Class | Expense Ratio |
|---|---|---|
| BHCHX | Institutional Shares | 0.85% |
| BHCUX | R6 Shares | 0.85% |
Top 10 Holdings
50.41% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 8.44% |
| UnitedHealth Group Incorporated | UNH | 7.75% |
| Intuitive Surgical, Inc. | ISRG | 5.03% |
| Fixed Inc Clearing Corp.Repo | n/a | 5.03% |
| Merck & Co., Inc. | MRK | 4.95% |
| Thermo Fisher Scientific Inc. | TMO | 4.57% |
| Boston Scientific Corporation | BSX | 4.40% |
| Vertex Pharmaceuticals Incorporated | VRTX | 4.01% |
| argenx SE | ARGX | 3.29% |
| Rocket Pharmaceuticals, Inc. | RCKT | 2.94% |